ログイン
お問い合わせ
有効性評価に基づく前立腺がん検診ガイドライン
書誌情報
引用文献
添付書類2
添付書類2：最終追加文献リスト 委員会20文献（AF1）+USPSTF5文献（治療不利益）+久道班1文献+外部評価委員9文献＝35文献
| ガイドライン引用No | 追加要因 | Auther | Title | Journal | Volumes | Issue | Pages | Year |
| 24 | 委員会 | Friedman GD, Hiatt RA, Quesenberry CP Jr, Selby JV. | Case-control study of screening for prostatic cancer by digital rectal examinations. | Lancet | 337 | 1526-9 | 1991 | |
| 25 | 委員会 | Richert-Boe KE, Humphrey LL, Glass AG, Weiss NS. | Screening digital rectal examination and prostate cancer mortality: a case-control study. | J Med Screen | 5 | 2 | 99-103 | 1998 |
| 27 | 委員会 | Jacobsen SJ, Bergstralh EJ, Katusic SK, Guess HA, Darby CH, Silverstein MD, Oesterling JE, Lieber MM. | Screening digital rectal examination and prostate cancer mortality: a population-based case-control study. | Urology | 52 | 2 | 173-9 | 1998 |
| 32 | 委員会（コクランSR引用文献） | Sandblom G, Varenhorst E, Löfman O, Rosell J, Carlsson P. | Clinical consequences of screening for prostate cancer: 15 years follow-up of a randomised controlled trial in Sweden. | Eur Urol | 46 | 717-24 | 2004 | |
| 33 | 委員会 | Aus G, Bergdahl S, Lodding P, Lilja H, Hugosson J. | Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, population-based randomized controlled trial. | Eur Urol | 51 | 3 | 659-64 | 2007 |
| 37 | 委員会 | Concato J, Wells CK, Horwitz RI, Penson D, Fincke G, Berlowitz DR, Froehlich G, Blake D, Vickers MA, Gehr GA, Raheb NH, Sullivan G, Peduzzi P. | The effectiveness of screening for prostate cancer: a nested case-control study. | Arch Intern Med | 166 | 38-43 | 2006 | |
| 38 | 委員会 | Kopec JA, Goel V, Bunting PS, Neuman J, Sayre EC, Warde P, Levers P, Fleshner N. | Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control study. | J Urol | 174 | 495-9 | 2005 | |
| 41 | 委員会 | Coldman AJ, Phillips N, Pickles TA. | Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity. | CMAJ | 168 | 1 | 31-5 | 2003 |
| 43 | 委員会 | Threlfall TJ, English DR, Rouse IL. | Prostate cancer in Western Australia: trends in incidence and mortality from 1985 to 1996. | Med J Aust | 169 | 21-4 | 1998 | |
| 44 | 委員会 | Skarsgard D, Tonita J. | Prostate cancer in Saskatchewan Canada, before and during the PSA era. | Cancer Causes Control | 11 | 79-88 | 2000 | |
| 45 | 委員会 | Majeed A, Babb P, Jones J, Quinn M. | Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-1998. | BJU Int | 85 | 1058-62 | 2000 | |
| 46 | 委員会 | Post PN, Kil PJ, Crommelin MA, Schapers RF, Coebergh JW. | Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in southeastern Netherlands, 1971-1995. | Eur J Cancer | 34 | 5 | 705-9 | 1998 |
| 47 | 委員会 | Brewster DH, Fraser LA, Harris V, Black RJ. | Rising incidence of prostate cancer in Scotland: increased risk or increased detection? | BJU Int | 85 | 463-73 | 2000 | |
| 48 | 委員会 | Roberts RO, Bergstralh EJ, Katusic SK, Lieber MM, Jacobsen SJ. | Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota. | J Urol | 161 | 529-33 | 1999 | |
| 50 | 委員会 | Jemal A, Ward E, Wu X, Martin HJ, McLaughlin CC, Thun MJ. | Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States. | Cancer Epidemiol Biomarkers Prev | 14 | 3 | 590-5 | 2005 |
| 51 | 委員会 | Baade PD, Coory MD, Aitken JF. | International trends in prostate-cancer mortality: the decrease is continuing and spreading. | Cancer Causes Control | 15 | 237-41 | 2004 | |
| 66 | 久31 | Kubota Y, Ito K, Imai K, Yamanaka H. | Effectiveness of mass screening for the prognosis of prostate cancer patients in Japanese communities. | Prostate | 50 | 4 | 262-9 | 2002 |
| 76 | 外部評価委員 | Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL, Graham E, Echols RM, Whalen E, Kowalsky SF. | Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. | Urology | 52 | 4 | 552-8 | 1998 |
| 77 | 外部評価委員 | Cooner WH, Mosley BR, Rutherford CL Jr, Beard JH, Pond HS, Terry WJ, Igel TC, Kidd DD. | Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. 1990. | J Urol | 167 | 2 Pt 2 | 966-75 | 2002 |
| 78 | 外部評価委員 | Rodríguez LV, Terris MK. | Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. | J Urol | 160 | 6 Pt 1 | 2115-20 | 1998 |
| 79 | 外部評価委員 | Djavan B, Waldert M, Zlotta A, Dobronski P, Seitz C, Remzi M, Borkowski A, Schulman C, Marberger M. | Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. | J Urol | 166 | 3 | 856-60 | 2001 |
| 81 | 外部評価委員 | Crawford ED, Haynes AL Jr, Story MW, Borden TA. | Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. | J Urol | 127 | 3 | 449-51 | 1982 |
| 82 | 外部評価委員 | Aron M, Rajeev TP, Gupta NP. | Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. | BJU Int | 85 | 6 | 682-5 | 2000 |
| 83 | 外部評価委員 | Norberg M, Holmberg L, Häggman M, Magnusson A. | Determinants of complications after multiple transrectal core biopsies of the prostate. | Eur Radiol | 6 | 4 | 457-61 | 1996 |
| 84 | 外部評価委員 | 熊谷章，小川大輔，小山敏樹，竹内一郎，大山格． | 経直腸的前立腺生検後にフルニエ壊疽を発症した管理不良な糖尿病患者の1例． | 日本泌尿器科学会雑誌 | 93 | 5 | 648-51 | 2002 |
| 85 | 外部評価委員 | 長谷川太郎，下村達也，山田裕紀，伊藤博之，加藤伸樹，長谷川倫男，浅野晃司，清田浩，池本庸，小野寺昭一，大石幸彦． | 経直腸的前立腺針生検による敗血症性ショックの1死亡例． | 感染症学雑誌 | 76 | 10 | 893-7 | 2002 |
| 86 | USPSTF | Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, Albertsen PC, Harlan LC, Potosky AL. | Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. | JAMA | 283 | 3 | 354-60 | 2000 |
| 87 | 委員会 | Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, Kupelian PA. | The use of treatments for erectile dysfunction among survivors of prostate carcinoma. | Cancer | 95 | 11 | 2397-407 | 2002 |
| 88 | USPSTF | Lu-Yao GL, McLerran D, Wasson J, Wennberg JE. | An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. | JAMA | 269 | 20 | 2633-6 | 1993 |
| 89 | USPSTF | Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson JE, Norlén BJ, Holmberg L; Scandinavian Prostatic Cancer Group Study Number 4. | Quality of life after radical prostatectomy or watchful waiting. | N Engl J Med | 347 | 11 | 790-6 | 2002 |
| 90 | 委員会 | Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC. | Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. | J Natl Cancer Inst | 96 | 18 | 1358-67 | 2004 |
| 91 | USPSTF | Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, Eley JW, Stephenson RA, Harlan LC. | Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. | J Natl Cancer Inst | 92 | 19 | 1582-92 | 2000 |
| 93 | USPSTF | Talcott JA, Rieker P, Clark JA, Propert KJ, Weeks JC, Beard CJ, Wishnow KI, Kaplan I, Loughlin KR, Richie JP, Kantoff PW. | Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. | J Clin Oncol | 16 | 1 | 275-83 | 1998 |
| 94 | 委員会 | Arai Y, Egawa S, Tobisu K, Sagiyama K, Sumiyoshi Y, Hashine K, Kawakita M, Matsuda T, Matsumoto K, Fujimoto H, Okada T, Kakehi Y, Terachi T, Ogawa O. | Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan. | BJU Int | 85 | 3 | 287-94 | 2000 |
| 95 | 委員会 | Hisasue S, Takahashi A, Kato R, Shimizu T, Masumori N, Itoh N, Tsukamoto T. | Early and late complications of radical retropubic prostatectomy: experience in a single institution. | Jpn J Clin Oncol | 34 | 5 | 274-9 | 2004 |
